HEMGENIX OPTIONS

Range of suitable people: CDEC discussed the uncertainty in the number of patients with reasonably severe to severe hemophilia B in Canada suitable for etranacogene dezaparvovec. Scientific industry experts consulted by CADTH indicated that some people who will be labeled as acquiring delicate or moderate illness may have a severe bleeding phenotyp